Stock Events

Stock Events

Vericel 

€30.09
0
+€1.22+4.23% Monday 06:03

Statistics

Day High
30.09
Day Low
30.09
52W High
39.4
52W Low
25.76
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q4 2025
Next
-0.13
0.04
0.21
0.38
Expected EPS
-0.1304406615
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ATQP.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Mimedx Group
MDXG
Mkt Cap537.69M
MiMedx Group, Inc. specializes in regenerative biomaterials similar to Vericel's focus on autologous cell therapies, making them direct competitors in the regenerative medicine space.
Brainstorm Cell Therapeutics
BCLI
Mkt Cap7.17M
Brainstorm Cell Therapeutics Inc. is involved in developing autologous stem cell therapies for debilitating neurological diseases, a field related to Vericel's therapeutic areas.
Mesoblast
MESO
Mkt Cap2.03B
Mesoblast Limited focuses on regenerative medicine and cell therapy, making it a competitor in the same innovative medical field as Vericel.
Fate Therapeutics
FATE
Mkt Cap177.91M
Fate Therapeutics, Inc. is engaged in the development of programmed cellular immunotherapies, competing with Vericel in the broader cell therapy market.
CRISPR Therapeutics
CRSP
Mkt Cap4.98B
CRISPR Therapeutics AG operates in the gene editing and cell therapy space, presenting a futuristic alternative to Vericel's current cell therapy solutions.
Sangamo Therapeutics
SGMO
Mkt Cap55.93M
Sangamo Therapeutics, Inc. works on genomic medicine, including gene therapy, competing in the innovative treatment space alongside Vericel.

About

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Show more...
CEO
Mr. Dominick C. Colangelo Esq.
Employees
398
Country
United States
ISIN
US92346J1088

Listings

MU
DE
ATQP.MU
STU
DE
ATQP.STU
F
DE
ATQP.F
XNAS
US
VCEL

0 Comments

Share your thoughts

FAQ

What is Vericel stock price today?▼
The current price of ATQP.MU is €30.09 EUR — it has increased by +4.23% in the past 24 hours. Watch Vericel stock price performance more closely on the chart.
What is Vericel stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Vericel stocks are traded under the ticker ATQP.MU.
Is Vericel stock price growing?▼
ATQP.MU stock has fallen by -3.53% compared to the previous week, the month change is a +8.47% rise, over the last year Vericel has showed a -11.51% decrease.
When is the next Vericel earnings date?▼
Vericel is going to release the next earnings report on May 07, 2026.
What were Vericel earnings last quarter?▼
ATQP.MU earnings for the last quarter are 0.38 EUR per share, whereas the estimation was 0.33 EUR resulting in a +15.16% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Vericel have?▼
As of May 06, 2026, the company has 398 employees.
In which sector is Vericel located?▼
Vericel operates in the Health & Wellness sector.
When did Vericel complete a stock split?▼
Vericel has not had any recent stock splits.
Where is Vericel headquartered?▼
Vericel is headquartered in Cambridge, United States.